BIOTIME INC 4
4 · BIOTIME INC · Filed Aug 18, 2015
Insider Transaction Report
Form 4
BIOTIME INCBTX
Cartt Stephen LaHue
Director
Transactions
- Purchase
Common Shares, no par value
2015-08-18$2.90/sh+17,200$49,832→ 155,125 total - Purchase
Common Shares, no par value
2015-08-14$2.65/sh+18,400$48,756→ 98,525 total - Purchase
Common Shares, no par value
2015-08-17$2.83/sh+39,400$111,478→ 137,925 total
Holdings
- 20,000
Option to Purchase Common Shares
Exercise: $3.43Exp: 2019-11-03→ Common Shares (20,000 underlying) - 20,000
Option to Purchase Common Shares
Exercise: $3.57Exp: 2020-06-30→ Common Shares (20,000 underlying)
Footnotes (5)
- [F1]The price of $2.6498 per share represents a weighted average of prices ranging from $2.63 to $2.679 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- [F2]The price of $2.8294 per share represents a weighted average of prices ranging from $2.69 to $2.99 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- [F3]The price of $2.8972 per share represents a weighted average of prices ranging from $2.86 to $3.00 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- [F4]Will become exercisable in four equal quarterly installments after the date of grant on July 1, 2015 based upon continued service on the board of directors.
- [F5]5,000 options became exercisable on December 31, 2014; March 31, 2015; and June 30, 2015. The remaining 5,000 options will become exercisable on September 30, 2015 based upon continued service on the board of directors.